Market Overview - The personal care products sector increased by 0.82% on September 19, with Beijia leading the gains [1] - The Shanghai Composite Index closed at 3820.09, down 0.3%, while the Shenzhen Component Index closed at 13070.86, down 0.04% [1] Stock Performance - Beijia (603059) closed at 34.19, up 2.46% with a trading volume of 70,200 shares and a turnover of 239 million yuan [1] - Baiya Co. (003006) closed at 28.83, up 2.13% with a trading volume of 29,500 shares and a turnover of 85.02 million yuan [1] - Zhongshun Jierou (002511) closed at 8.52, up 1.79% with a trading volume of 164,400 shares and a turnover of 140 million yuan [1] - Liangmian Needle (600249) closed at 6.19, up 1.14% with a trading volume of 241,200 shares and a turnover of 148 million yuan [1] - Other notable stocks include Dengkang Oral (001328) at 39.11, up 0.51%, and Yiyi Co. (001206) at 28.89, up 0.45% [1] Capital Flow - The personal care products sector experienced a net outflow of 31.20 million yuan from institutional investors, while retail investors saw a net inflow of 22.65 million yuan [2] - The sector's overall capital flow indicates a mixed sentiment among different investor types [2] Individual Stock Capital Flow - Liangmian Needle (600249) had a net inflow of 11.98 million yuan from institutional investors, while retail investors had a net outflow of 16.54 million yuan [3] - Beijia (603059) saw a net inflow of 1.61 million yuan from institutional investors, with retail investors experiencing a net outflow of 7.37 million yuan [3] - Zhongshun Jierou (002511) had a net outflow of 2.91 million yuan from institutional investors, while retail investors had a net inflow of 3.65 million yuan [3]

Group 1 - The company, Jieya Co., announced a profit distribution plan for the first half of 2025, proposing a cash dividend of 1 RMB per 10 shares to all shareholders, including tax [2] - The record date for the dividend is set for September 25, 2025, while the ex-dividend date is September 26, 2025 [2]

Group 1 - The personal care products sector experienced a decline of 2.18% on September 18, with Jieya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3831.66, down 1.15%, while the Shenzhen Component Index closed at 13075.66, down 1.06% [1] - A table detailing the individual stock performance within the personal care products sector was provided [1] Group 2 - On the same day, the personal care products sector saw a net outflow of 134 million yuan from main funds, while retail funds had a net inflow of 87.17 million yuan and speculative funds saw a net inflow of 46.81 million yuan [2] - A table showing the fund flow for individual stocks in the personal care products sector was included [2]

Group 1 - The company, Jieya Co., announced a cash dividend distribution of 1 RMB per 10 shares to all shareholders, totaling approximately 11.26 million RMB (including tax) based on a total share capital of about 113 million shares as of the announcement date [1] - The record date for the dividend is set for September 25, 2025, and the ex-dividend date is September 26, 2025 [1]

证券代码：301108 证券简称：洁雅股份 公告编号：2025-077 铜陵洁雅生物科技股份有限公司 2025年半年度分红派息实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 铜陵洁雅生物科技股份有限公司（以下简称"公司"）2025 年半年度权益分 派方案已获 2025 年 9 月 15 日召开的 2025 年第五次临时股东会审议通过，现将权 益分派事宜公告如下： 一、股东会审议通过利润分配方案等情况 1、公司于 2025 年 9 月 15 日召开 2025 年第五次临时股东会，审议通过了《关 于 2025 年半年度利润分配方案的议案》。公司 2025 年半年度利润分配方案为： 公司以截至公告日的总股本 112,556,252 股为基数，拟向全体股东每 10 股派发现 金红利 1.00 元（含税），合计派发现金红利 11,255,625.20 元人民币（含税）。本 次利润分配不进行资本公积转增股本，不送红股，剩余未分配利润滚存至下一年 度，用于支持公司经营发展。 2、本次分配方案披露至实施期间，公司股本总额未发生变化。 3、本次实施的分配方案与股东会审 ...

Market Overview - The personal care products sector experienced a significant increase of 28.19% on September 17, with Beijia leading the gains [1] - The Shanghai Composite Index closed at 3876.34, up 0.37%, while the Shenzhen Component Index closed at 13215.46, up 1.16% [1] Stock Performance - Beijia (603059) closed at 32.96, with a rise of 2.33% and a trading volume of 52,600 shares, resulting in a transaction value of 173 million yuan [1] - Baiya Co. (003006) closed at 29.20, up 1.81%, with a trading volume of 30,300 shares and a transaction value of 88.45 million yuan [1] - Dengkang Oral (001328) closed at 40.62, increasing by 1.32%, with a trading volume of 23,600 shares and a transaction value of 96.33 million yuan [1] - Zhongshun Jierou (002511) closed at 8.48, up 0.71%, with a trading volume of 136,300 shares and a transaction value of 115 million yuan [1] - Stable Medical (300888) closed at 39.74, with a slight increase of 0.23%, trading 78,700 shares for a total value of 316 million yuan [1] Capital Flow - The personal care products sector saw a net outflow of 8.42 million yuan from institutional investors and 13.61 million yuan from speculative funds, while retail investors contributed a net inflow of 22.03 million yuan [2] - The capital flow data indicates that the sector is experiencing mixed investor sentiment, with institutional and speculative funds withdrawing while retail investors are increasing their positions [2][3] Individual Stock Capital Flow - For Yanjing Co. (300658), there was a net inflow of 27.24 million yuan from institutional investors, while speculative funds saw a net outflow of 14.17 million yuan [3] - Beijia (603059) had a net inflow of 4.35 million yuan from institutional investors, with speculative funds contributing a net inflow of 10.65 million yuan [3] - Dengkang Oral (001328) experienced a net inflow of 1.30 million yuan from institutional investors, while retail investors contributed a net inflow of 2.24 million yuan [3]

Group 1 - The core viewpoint of the news is that Jeya Co., Ltd. has shown significant trading activity and financial performance, with a notable increase in stock price and financing activities [1][2] - On September 15, Jeya Co., Ltd. experienced a stock price increase of 3.95%, with a trading volume of 134 million yuan [1] - The financing buy-in amount on the same day was 17.33 million yuan, while the financing repayment was 17.05 million yuan, resulting in a net financing buy of 283,100 yuan [1] Group 2 - As of September 15, the total financing and securities balance for Jeya Co., Ltd. was 45.90 million yuan, accounting for 1.16% of the circulating market value, indicating a high level compared to the past year [1] - The company’s main business revenue composition includes wet wipes at 84.62%, facial masks at 11.95%, and personal care products at 1.86% [1] - For the first half of 2025, Jeya Co., Ltd. achieved an operating income of 310 million yuan, representing a year-on-year growth of 8.79%, and a net profit attributable to shareholders of 32.58 million yuan, up 22.55% year-on-year [2]

证券代码：301108 证券简称：洁雅股份 公告编号：2025-076 铜陵洁雅生物科技股份有限公司 2025年第五次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1. 本次股东会未出现否决议案的情形。 2. 本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开情况 1、会议召开时间 （1）现场会议召开时间：2025 年 9 月 15 日（星期一）14:30。 （2）网络投票时间：2025 年 9 月 15 日（星期一）。 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 9 月 15 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投 票系统（http://wltp.cninfo.com.cn）投票的时间为 2025 年 9 月 15 日 9:15 至 15:00 期间的任意时间。 2、会议召开地点：安徽省铜陵市狮子山经济开发区铜井东路 1928 号铜陵洁 雅生物科技股份有限公司会议室。 3、会议召开方式：本次股东会采用现场表决与网络投票相结合的方式召 ...

天禾律师 股东会法律意见书 安徽天禾律师事务所 关于铜陵洁雅生物科技股份有限公司 2025 年第五次临时股东会法律意见书 天律意 2025 第 02493 号 致：铜陵洁雅生物科技股份有限公司 根据《中华人民共和国公司法》（下称"《公司法》"）、《中华人民共和 国证券法》（下称"《证券法》"）、中国证券监督管理委员会《上市公司股东 会规则》（下称"《股东会规则》"）以及《铜陵洁雅生物科技股份有限公司章 程》（下称"《公司章程》"）的有关规定，安徽天禾律师事务所接受铜陵洁雅 生物科技股份有限公司（下称"公司"）委托，指派冉合庆、杨春波律师（下称 "天禾律师"）出席公司 2025 年第五次临时股东会（下称"本次股东会"）， 并对本次股东会相关事项进行见证，出具法律意见。 本法律意见书是天禾律师根据对本次股东会事实的了解及对我国现行法律、 法规和规范性文件的理解而出具的。 天禾律师同意将本法律意见书作为本次股东会的法定必备文件予以公告，并 依法对所出具的法律意见书承担责任。 天禾律师根据《证券法》相关规定的要求，按照律师行业公认的业务标准、 道德规范和勤勉尽责精神，对本次股东会的召集、召开、与会人员资格、表决程 序 ...

Group 1: Company Performance and Strategy - The company reported Q1 2025 revenue of 124 million CNY and a net profit of 10.06 million CNY, indicating a focus on improving production capacity utilization [3] - The company aims to achieve a production capacity utilization rate of over 80% starting from Q2 2025, with current main production lines operating at full capacity [3] - The company is actively expanding its international brand client base while maintaining a focus on OEM services [3][4] Group 2: Product Development and Market Position - The market share and quarterly growth rate of wet wipes were discussed, with the company currently operating at an 80% capacity utilization rate for wet wipes production [3] - The company is exploring plans to expand the production capacity and product line for wet wipes [3] - There is an ongoing effort to develop proprietary brand business, although the company primarily focuses on OEM production at this stage [3] Group 3: U.S. Operations and Future Outlook - The U.S. factory is in the early stages of setup, including facility renovations and equipment installation, with production expected to commence by mid-2026 [3][4] - The company plans to enhance operational efficiency in the U.S. through automation and optimized management processes [3] - Investors are advised to be cautious due to potential uncertainties related to local government approvals and recruitment affecting the U.S. factory's production timeline [4]